Compare LEXX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | AQMS |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 20.9M |
| IPO Year | N/A | 2015 |
| Metric | LEXX | AQMS |
|---|---|---|
| Price | $0.65 | $4.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.50 | ★ $12.00 |
| AVG Volume (30 Days) | 173.0K | ★ 739.9K |
| Earning Date | 04-14-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $522,000.00 | N/A |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $78.83 | $550.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.05 | N/A |
| 52 Week Low | $0.46 | $3.37 |
| 52 Week High | $1.90 | $39.40 |
| Indicator | LEXX | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 42.89 |
| Support Level | $0.67 | $4.01 |
| Resistance Level | $0.79 | $4.78 |
| Average True Range (ATR) | 0.07 | 0.41 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 28.97 | 40.85 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.